NKGen Biotech, Inc.
NKGNDelisted Jul 17, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001845459
NKGen Biotech, Inc. was delisted on Jul 17, 2025; its insiders filed their last Form 4 on Jun 2, 2025; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding NKGen Biotech, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 19 | 25 | +6 |
| Shares | 3.75M | 8.35M | +4.60M (+122.5%) |
| Value | $1.23M | $5.07M | +$3.84M (+312.2%) |
New holders (9)
Institutions that held NKGen Biotech, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pathstone Holdings, LLC | 2,797,661 | $1.83M | 0.01% |
| Kepos Capital LP | 230,022 | $151.0K | 0.13% |
| Magnetar Financial LLC | 267,508 | $95.5K | 0.00% |
| Advisory Research Inc | 43,088 | $28.2K | 0.00% |
| XTX Topco Ltd | 33,625 | $22.0K | 0.00% |
| Periscope Capital Inc. | 25,000 | $16.4K | 0.01% |
| Two Sigma Investments, LP | 22,356 | $14.6K | 0.00% |
| SkyOak Wealth, LLC | 13,164 | $8.63K | 0.00% |
| SBI Securities Co., Ltd. | 902 | $591 | 0.00% |
Sold out (3)
Institutions that held NKGen Biotech, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Citadel Advisors LLC | 95,438 | $36.1K |
| Towneley Capital Management, Inc | 10,000 | $3.78K |
| HRT Financial LP | 10,318 | $3.00K |